CHALLENGE ACCEPTED
DEAD

Serial Number

87516334

Owner

Avista Pharma Solutions, Inc.

Attorney

Lawrence M. Green

First Use Date

May 5, 2017

Filing Date

Jul 5, 2017

Add to watchlist:

No watchlists yet
View on USPTO

CHALLENGE ACCEPTED Trademark

Serial Number: 87516334 • Registration: 5395382

CHALLENGE ACCEPTED is a trademark filed by Avista Pharma Solutions, Inc. on July 5, 2017. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Avista Pharma Solutions, Inc. (3 trademarks)

3501 Tricenter Blvd, Suite C
Durham, NC 27713

Entity Type: 03

Trademark Details

Filing Date

July 5, 2017

Registration Date

February 6, 2018

First Use Anywhere

May 5, 2017

First Use in Commerce

May 5, 2017

Published for Opposition

November 21, 2017

Cancellation Date

August 16, 2024

Goods & Services

Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others

Scientific, technological and testing services, namely, microbiological testing in the pharmaceutical and medical device industries; container closure integrity testing; bacterial filter integrity testing; mycoplasma testing; sterilization validation testing; cleaning validation testing; package validation testing; accelerated aging studies, namely, conducting technical research in the field of product aging; disinfectant qualification programs for clean rooms, namely, developing quality control standards for clean rooms; clean room testing and support services in the nature of monitoring clean room manufacturing practices for quality control operational and design purposes; clean room environmental monitoring services, namely, air surface monitoring, personnel monitoring in the nature of conducting surveys to determine if clean room employees meet employee clean room requirements and standards, temperature and humidity monitoring, pressure differential monitoring, incubation analysis and reporting and isolate characterization and identification; product research and process chemistry services in the pharmaceutical industry; analytical testing and development services for the pharmaceutical industry, namely, structural determination and impurity identification; material characterization, namely, materials testing; evaluation of potential genotoxic impurities in the production of drugs; impurity isolation, namely, chemical laboratory services in the field of impurity isolation for the pharmaceutical industry; analysis of raw materials to specifications; analytical testing to monitor the synthesis and release of drugs; bioanalytical analysis to support discovery and preclinical drug metabolism studies; conducting stability studies of pharmaceutical products; and research and development of drug formulations

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 12, 2025 ASCK
CANCELLED SEC. 8 (6-YR)
Aug 16, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 6, 2023 REM1
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 16, 2020 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 10, 2020 TCCA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 11, 2019 ASCK
REGISTERED-PRINCIPAL REGISTER
Feb 6, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 21, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 21, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 1, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2017 CNSA
ASSIGNED TO EXAMINER
Sep 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2017 NWOS
NEW APPLICATION ENTERED
Jul 8, 2017 NWAP